UK Wedding News
18/06/2013
Suzannah Kidd, 34, from Herts gave birth to her second son Heath in April after taking part in a trial for the new form of IVF, The Telegraph has said.
The treatment, which has been developed by British doctors, is said to reduce the risk of women developing a potentially life-threatening condition called ovarian hyperstimulation syndrome (OHSS). This is when, instead of producing a few eggs as desired, the ovaries produce lots in response to the fertility drugs. While most women with OHSS will have mild symptoms and recover, those few with severe OHSS become very ill and can die.
Now UK experts say they have found a way to make IVF safer by using the 'kisspeptin' treatment.
A total of 30 women have now been treated with the new technique, with 28 falling pregnant.
Mrs Kidd and her husband Calum are the first couple to successfully give birth following the new treatment.
However, while experts welcomed the breakthrough, they did warn it would be years before the treatment is made widely available as further studies are needed.
Professor Waljit Dhillo, an endocrinologist at Imperial College London who has been leading the study, said that kisspeptin allowed them to stimulate the ovaries in a more controlled manner and reduce the risks of OHSS.
He said: "hCG is very long acting – it has a half-life of around eight days and so this increases the risk of OHSS.
"Kisspeptin lasts for far less time. We think it is the hormone that causes ovulation in women normally, so we are trying a more natural approach."
While Geoffrey Trew, a consultant in reproductive medicine at Hammersmith Hospital who treated Mrs Kidd, added: "With IVF, we are dealing with an otherwise healthy group of people, so the last thing we want to do is put them at risk.
"What we have shown with this trial is that kisspeptin works and that we can get women pregnant using it with the birth of a healthy little boy.
"We then want to study it in the high risk group of patients to see if we can reduce the risk to that group."
The study was funded by the Medical Research Council UK and the National Institute for Health Research. The results are to be presented this week at The Endocrine Society's annual meeting in San Francisco, California.
(JP/CD)
20/03/2020
LeToya Luckett-Walker Is Pregnant
Charlotte Crosby Finds New Romance
Lydia Bright Gets Candid About Giving Birth
Lana Del Ray Splits From Boyfriend
Angelica Ross Learns Of Boyfriend's Secret Life
Ashley Graham's Breastfeeding Struggle
Susanna Reid's Mother's Day Plans
Lin-Manuel Miranda Homeschooling Kids
Kristen Bell Speaks Of Pride For Daughters
Prince George & Princess Charlotte Now Homeschooled
First Baby Born Using New IVF Treatment
The first baby has been born using a new, 'safer' method of IVF treatment.Suzannah Kidd, 34, from Herts gave birth to her second son Heath in April after taking part in a trial for the new form of IVF, The Telegraph has said.
The treatment, which has been developed by British doctors, is said to reduce the risk of women developing a potentially life-threatening condition called ovarian hyperstimulation syndrome (OHSS). This is when, instead of producing a few eggs as desired, the ovaries produce lots in response to the fertility drugs. While most women with OHSS will have mild symptoms and recover, those few with severe OHSS become very ill and can die.
Now UK experts say they have found a way to make IVF safer by using the 'kisspeptin' treatment.
A total of 30 women have now been treated with the new technique, with 28 falling pregnant.
- - - - - - Advertisement - - - - - -
Mrs Kidd and her husband Calum are the first couple to successfully give birth following the new treatment.
However, while experts welcomed the breakthrough, they did warn it would be years before the treatment is made widely available as further studies are needed.
Professor Waljit Dhillo, an endocrinologist at Imperial College London who has been leading the study, said that kisspeptin allowed them to stimulate the ovaries in a more controlled manner and reduce the risks of OHSS.
He said: "hCG is very long acting – it has a half-life of around eight days and so this increases the risk of OHSS.
"Kisspeptin lasts for far less time. We think it is the hormone that causes ovulation in women normally, so we are trying a more natural approach."
While Geoffrey Trew, a consultant in reproductive medicine at Hammersmith Hospital who treated Mrs Kidd, added: "With IVF, we are dealing with an otherwise healthy group of people, so the last thing we want to do is put them at risk.
"What we have shown with this trial is that kisspeptin works and that we can get women pregnant using it with the birth of a healthy little boy.
"We then want to study it in the high risk group of patients to see if we can reduce the risk to that group."
The study was funded by the Medical Research Council UK and the National Institute for Health Research. The results are to be presented this week at The Endocrine Society's annual meeting in San Francisco, California.
(JP/CD)
Top stories
20/03/2020
LeToya Luckett-Walker Is Pregnant
Charlotte Crosby Finds New Romance
Lydia Bright Gets Candid About Giving Birth
Lana Del Ray Splits From Boyfriend
Angelica Ross Learns Of Boyfriend's Secret Life
Ashley Graham's Breastfeeding Struggle
Susanna Reid's Mother's Day Plans
Lin-Manuel Miranda Homeschooling Kids
Kristen Bell Speaks Of Pride For Daughters
Prince George & Princess Charlotte Now Homeschooled
